Myxedema ascites with an extremely elevated CA125 level: A case report

Endocrine Journal

Volumn 54, Issue 4, 2007, Pages 601-604

  Kanehara, Hideo ^a   Bando, Yukihiro ^a   Tomita, Manabu ^a   Kontani, Makoto ^a   Takegoshi, Yasuo ^a   Tanaka, Nobuyoshi ^a  

^a FUKUI KEN SAISEIKAI HOSPITAL   (Japan)

Author keywords

Carbohydrate antigen 125; Hypothyroidism; Myxedema ascites

Indexed keywords

CA 125 ANTIGEN; THYROID HORMONE; THYROTROPIN; THYROXINE;

AGED; ARTICLE; ASCITES; BLOOD ANALYSIS; CASE REPORT; CLINICAL EXAMINATION; DISEASE ASSOCIATION; FEMALE; FREE THYROXINE INDEX; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; LABORATORY TEST; MYXEDEMA; PHYSICAL EXAMINATION; SYMPTOMATOLOGY;

AGED; ASCITES; CA-125 ANTIGEN; FEMALE; HUMANS; HYPOTHYROIDISM; MYXEDEMA; THYROXINE; TUMOR MARKERS, BIOLOGICAL;

EID: 34548696373     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K06-185     Document Type: Article

References (13)

1. Kiya Y, Miura SI, Zhang B, Urata H, Saku K (2006) Effect of levothyroxine on total lipid profiles as assessed by analytical capillary isotachophoresis in a patient with hypothyroidism. Endocr J 53: 865-868.
2. Canaris GJ, Steiner JF, Ridgway EC (1997) Do traditional symptoms of hypothyroidism correlate with biochemical disease? J Gen Intern Med 12: 544-550.
3. Malik R, Hodgson H (2002) The relationship between the thyroid gland and the liver. QJM 95: 559-569.
4. Bast RCJ, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC (1981) Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 68: 1331-1339.
5. Kabawat SE, Bast RC Jr, Bhan AK, Welch WR, Knapp RC, Colvin RB (1983) Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125. Int J Gynecol Pathol 2: 275-285.
6. Krishnan STM, Philipose Z, Rayman G (2002) Hypothyroidism mimicking intra-abdominal malignancy. BMJ 325: 946-947.
7. De Castro F, Bonacini M, Walden JM, Schubert TT (1991) Myxoedema ascites report of two cases and review of the literature. J Clin Gastroenterol 13: 411-414.
8. Duarte DR, Chang CV, Minicucci MF, Zornoff LA, Inoue RM, Matsui M, Okoshi MP, Azevedo PS, Matsubara LS, Paiva SA (2006) Myxedema ascites with elevated serum CA125 concentration. Am J Med Sci 331: 103-104.
9. Depeczynski B, Ward R, Eisman J (1996) The association between myxedematous ascites and extreme elevation of serum tumor markers. J Clin Endocrinol Metab 81: 4175.
10. Hashimoto T, Matsubara F (1989) Changes in the tumor marker concentration in female patients with hyper-, eu- and hypothyroidism. Endocrine Jpn 36: 873-879.
11. Seo T, Ikeda Y, Onaka H, Hayashi T, Kawaguchi K, Kotake C, Toda T, Kobayashi K (1993) Usefulness of serum CA125 measurement for monitoring pericardial effusion. Jpn Circ J 57: 489-494.
12. Sevinc A, Sari R, Camci C, Buyukberber S (2000) A secondary interpretation is needed on serum CA125 levels in case of serosal involvement. J R Soc Health 120: 268-270.
13. Sevinc A, Buyukberber S, Sari R, Kiroglu Y, Turk HM, Ates M (2000) Elevated serum CA 125 levels in hemodialysis patients with peritoneal, pleural, or pericardial fluids. Gynecol Oncol 77: 254-257.